Haem arginate interferes with estimation of carcinoembryonic antigen

Annals of Clinical Biochemistry

Volumn 38, Issue 3, 2001, Pages 275-276

  Gross, U ^a   Schurek, J O ^a   Doss, M ^a   Doss, Manfred O ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; HEME ARGINATE;

ANALYTICAL ERROR; ANTIGEN DETECTION; ARTICLE; DRUG CROSS REACTIVITY; PRIORITY JOURNAL;

ADULT; ALPHA-FETOPROTEINS; ARGININE; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, HEPATOCELLULAR; CHEMISTRY, CLINICAL; ERYTHROCYTES; FALSE POSITIVE REACTIONS; FEMALE; HEME; HEMOGLOBINS; HUMANS; PORPHYRIAS, HEPATIC; PROSTATE-SPECIFIC ANTIGEN;

EID: 0035010420     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/0004563011900515     Document Type: Article

References (5)

1. 1 Andersson C, Bjersing L, Lithner F. The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Intern Med 1996; 240: 195-201
2. 2 Kauppinen R, Mustajoki P. Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer 1988; 57: 117-20
3. 3 Doss MO, Sassa S. The porphyrias. In: Noe DA, Rock RC, eds. Laboratory Medicine. The Selection and Interpretation of Clinical Laboratory Studies. Baltimore, Maryland: Williams & Wilkins, 1994: 535-53
4. 4 Mustajoki P, Nordmann Y. Early administration of heme arginate for acute porphyric attack. Arch Intern Med 1993; 53: 2004-8
5. 5 Gherardi C, Roumier A-S, Dubucquoi S, Dessaint J-P. Les cryptates appliqués au dosage des marqueurs tumoraux (ACE, AFP, CA 15.3, CA 19.9): évaluation de l'automate Kryptor (Cis-Bio). Ann Biol Clin 1998; 56: 92-5